Annovis Bio upgraded to Buy from Hold at Maxim
PremiumThe FlyAnnovis Bio upgraded to Buy from Hold at Maxim
20d ago
Annovis Bio says FDA clears company to launch Phase 3 Alzheimer’s studies
Premium
The Fly
Annovis Bio says FDA clears company to launch Phase 3 Alzheimer’s studies
1M ago
Annovis Bio Files Patents for Neurodegenerative Combination Therapies
Premium
Company Announcements
Annovis Bio Files Patents for Neurodegenerative Combination Therapies
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
Annovis Bio reports Q2 EPS (44c), consensus (63c)
Premium
The Fly
Annovis Bio reports Q2 EPS (44c), consensus (63c)
3M ago
Annovis Bio Inc options imply 5.8% move in share price post-earnings
Premium
The Fly
Annovis Bio Inc options imply 5.8% move in share price post-earnings
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Annovis Bio announces preclinical data on buntanetap with GLP-1 agonist
Premium
The Fly
Annovis Bio announces preclinical data on buntanetap with GLP-1 agonist
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100